Sui denies insider selling allegations as token surge triggers $400M sell-off
The Sui token has experienced a dramatic rise, with its value soaring ...
Eli Lilly to invest $364M in UK trial linking obesity drug to employment
Eli Lilly, the US pharmaceutical giant behind weight-loss drugs like Zepbound and ...
Sui denies insider selling allegations as token surge triggers $400M sell-off
The Sui token has experienced a dramatic rise, with its value soaring ...
Eli Lilly to invest $364M in UK trial linking obesity drug to employment
Eli Lilly, the US pharmaceutical giant behind weight-loss drugs like Zepbound and ...
Alibaba stock forecast: is BABA a good buy now?
Alibaba Group (BABA) stock price has done well, helped by the recent ...
How India-Canada tensions could disrupt $9.8 billion in annual trade
India and Canada’s diplomatic ties took another hit when Canada suggested that ...
Warren Buffett buys more Sirius XM stock: here’s why I wouldn’t
Sirius XM Holdings Inc. (NASDAQ: SIRI) is experiencing upward momentum on Monday ...
Daron Acemoglu, Simon Johnson, James Robinson win Nobel Prize for research on why countries succeed or fail
Three distinguished economists—Daron Acemoglu, Simon Johnson, and James Robinson—have been awarded the ...
USD to ZIG: New Zimbabwe currency enters a dark phase
The Zimbabwe ZiG has become one of the worst-performing currencies this year ...
Sui denies insider selling allegations as token surge triggers $400M sell-off
The Sui token has experienced a dramatic rise, with its value soaring by over 120% ...
Eli Lilly to invest $364M in UK trial linking obesity drug to employment
Eli Lilly, the US pharmaceutical giant behind weight-loss drugs like Zepbound and Mounjaro, has announced ...